OVANTI LIMITED — Director's Dealing 2008

Jan 21, 2008

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity OCCUPATIONAL & MEDICAL INNOVATIONS LIMITED ABN 11 091 192 871

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Terence James SKENE
Date of last notice	14 January 2008
Date of this notice	21 January 2008

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Refer attached
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Refer attached
Date of change	17 January 2008
No. of securities held prior to change	Refer attached
Class	Refer attached
Number acquired	Refer attached
Number disposed	Refer attached
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Shares issued for non cash consideration at rate of $0.505 per share in satisfaction of payment of fees totalling $5,000.
No. of securities held after change	Refer attached

• See chapter 19 for defined terms.

11/3/2002

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Ordinary shares issued in settlement of charge for fees totalling $5,000 for services rendered over and above directors fees.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	Nil
Nature of interest	Nil
Name of registered holder (if issued securities)	Nil
Date of change	Nil
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	Nil
Interest acquired	Nil
Interest disposed	Nil
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	Nil
Interest after change	Nil

• See chapter 19 for defined terms. Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

ATTACHMENT TO APPENDIX 3Y CHANGE OF DIRECTORS INTERESTS

TERENCE JAMES SKENE

Summary Number of securities held prior to change Number acquired Number disposed Number of securities held after the change Value/consideration on shares acquired Directly Shares Options (unlisted expiry 30/09/09) Indirectly held (see Note 1 below) Fellcroft Pty Ltd (ATF for Skene Family Trust) Kingston Park Holdings Pty Ltd	Ordinary Shares Options 787,441 714,286 9,901 - - -
	797,342 714,286
	$5,000 -
	Opening Closing 714,286 714,286 714,286 714,286 47,700 47,700 25,455 35,356

Note 1: Entities in which the Director has a beneficial interest

21 January 2008

• See chapter 19 for defined terms.

11/3/2002

Appendix 3Y Page 3